Mercer Global Advisors Inc Neurocrine Biosciences Inc Transaction History
Mercer Global Advisors Inc
- $35.2 Billion
- Q1 2024
A detailed history of Mercer Global Advisors Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 7,693 shares of NBIX stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,693
Previous 5,292
45.37%
Holding current value
$1.09 Million
Previous $697,000
52.37%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NBIX
# of Institutions
628Shares Held
94.4MCall Options Held
505KPut Options Held
343K-
Black Rock Inc. New York, NY13.8MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.41 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$568 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$326 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$320 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...